TABLE 3

Incidence of solicited local adverse eventsa

Type of AENo. (%) in vaccination group with AE
Flexyn2a (n = 12)Flexyn2a + alum (n = 12)Placebo (n = 6)b
1st vacc2nd vacc1st vacc2nd vacc1st vacc2nd vacc
Any AE3 (25)5 (42)4 (33)7 (58)2 (33)
Pain2 (17)2 (17)1 (8)3 (25)
Tenderness2 (17)4 (33)3 (25)7 (58)2 (33)
Redness
Swelling1 (8)
  • a AE data were collected for subjects after the first and second vaccinations (vacc).

  • b One subject received only the first injection.